The global anorectal malformation treatment market is expected to surpass an impressive valuation of US$ 794.91 million in 2023 and is projected to exhibit a CAGR of 7.4% from 2023 to 2033, reaching US$ 1,475.19 million. The market is driven by a number of factors, including the rising prevalence of ARM, increasing awareness of the …
Category Archives: Healthcare Trends
Global Bartonellosis Therapeutics Market is poised to hit a staggering US$ 3.72 Billion by 2033, driven by ground breaking treatments | FMI
The global bartonellosis therapeutics market size is anticipated to achieve an amazing valuation of US$ 1.2 Billion in 2023 and will reach US$ 3.72 billion by 2033, rising at a CAGR of 12% from 2023 to 2033. Future Market Insights (FMI) claims that. Bartonellosis is becoming more common, people are becoming more aware of it, …
Robotic Assisted Endovascular Systems Market Gears Up for a Valuation of US$ 214.7 Million by 2033-FMI Study
The global Robotic Assisted Endovascular Systems Market is poised for significant growth, with a projected market size of US$ 94.0 million in 2023 and an anticipated CAGR of 8.6% throughout the forecast period, propelling it to a valuation of US$ 214.7 million by 2033. The Robotic Assisted Endovascular Systems Market involves the application of cutting-edge robotic technology …
Global Abetalipoproteinemia Management Market is expected to reach US$ 341 Million by 2033, as per FMI’s report
The Abetalipoproteinemia Management Market is anticipated to expand from its current estimated value of US$ 147 million in 2023 to US$ 341 million by 2033, at a CAGR of 8.78%. The growing popularity of imaging tests like hepatic scans or ultrasonography to evaluate changes in fatty liver, as well as magnetic resonance imaging (MRI) of …
Skin Cancer Detection Devices Market Envisions a US$ 2.95 Billion Horizon by 2033-FMI Study
The market for Skin Cancer Detection Devices is expected to be worth US$ 959.6 million in 2023. The market is expected to exceed US$ 2.95 billion by 2033, growing at an 11.9% CAGR during the forecast period. Growing skin cancer incidences and skin cancer awareness are driving market growth. Because skin cancer affects people of all ages …
Global PD1 Non-Small Cell Lung Cancer Treatment Market value to surge to US$ 61 Billion by 2033, riding on an impressive CAGR of 8.51% | FMI
According to a recent study published by Future Market Insights, the PD1 non-small cell lung cancer treatment market is slated to reach a valuation of US$ 26.96 Billion in 2023, and will further increase to US$ 61 Billion, registering a CAGR of 8.51% from 2023 to 2033. Rising prevalence of non-small cell lung cancer is …
Global Central Pain Syndrome Management Market is anticipated to reach US$ 100 Billion by 2033, propelled by a 5% CAGR | FMI
A recently published study by FMI expects the global central pain syndrome management market to augment at a 5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 100 Billion is expected for the market. As per the World Health Organization (WHO), the share of the world’s …
Small Molecule-Drug Conjugates Market Anticipated to Reach US$ 3.65 Billion by 2033-FMI Study
According to a recent market survey conducted by Future Market Insights (FMI), the global Small Molecule-Drug Conjugates Market will be valued at US$ 1.18 billion in 2026 and is expected to reach US$ 3.65 billion by 2033.The increased use of personalised medicines is propelling market growth. Small molecule drug conjugates (SMDCs), a promising strategy for targeted therapy, …
Global Pork Tapeworm Infection Treatment Market Expected to Exceed US$ 25.17 Billion by 2033, with Albendazole Drugs Projected as Leading Products – FMI Report
According to Future Market Insights, the global pork tapeworm infection treatment market is expected to grow at a CAGR of 8% between 2023 and 2033, reaching US$ 25.17 Billion by 2033. It is expected that the market will further grow as the number of test kits and devices continues to increase. It is expected that …
Spectral Cell Analyzers Market Poised to Surpass US$ 3.0 Billion by 2033, Riding a 7.2% CAGR Wave-FMI Study
In 2023, the spectral cell analyzers market is expected to be worth US$ 1.5 billion. The market is expected to reach US$ 3.0 billion by 2033, expanding at a 7.2% CAGR throughout the forecast period. The spectral cell analyzers industry is driven by rising demand in research and clinical applications. Immunology, cancer research, drug development, and clinical …